Cano Health, Inc. (JWS) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20
	10-K	10-K	10-K
Revenues	2,738.9	1,609.4	831.6
Revenue growth	70.2%	93.5%
Cost of goods sold	0.0	0.0	0.0
Gross profit	2,738.9	1,609.4	831.6
Gross margin	100.0%	100.0%	100.0%
Selling, general and administrative	422.4	252.1	104.0
Other operating expenses	2,322.8	1,410.4	666.3
EBITDA [+]	-6.4	-53.2	61.3
EBITDA growth	-88.1%	-186.8%
EBITDA margin	-0.2%	-3.3%	7.4%
Depreciation	19.0	10.9	6.7
EBITA	-25.4	-64.1	54.6
EBITA margin	-0.9%	-4.0%	6.6%
Amortization of intangibles	71.6	38.5	11.8
EBIT [+]	-97.0	-102.6	42.8
EBIT growth	-5.5%	-339.9%
EBIT margin	-3.5%	-6.4%	5.1%
Non-recurring items [+]	339.8	32.6	43.0
Asset impairment	323.0
Unusual expense	-5.6
Loss on contingent liability	-5.0	-11.7	0.1
Interest expense, net [+]	62.5	51.3	33.7
Interest expense	62.5	51.3	34.0
Interest income	0.0	0.0	0.3
Other income (expense), net [+]	73.0	69.8	-36.5
Gain (loss) on debt retirement	-1.4	-13.1	-23.3
Change in fair value of warrants	72.8	82.9
Other	1.7	0.0	-0.5
Pre-tax income	-426.2	-116.7	-70.4
Income taxes	2.2	0.0	0.7
Minority interest	-221.1	-98.7
Net income	-207.3	-18.0	-71.1
Net margin	-7.6%	-1.1%	-8.5%

Basic EPS [+]	($0.95)	($0.11)	($0.82)
Growth	794.9%	-87.2%
Diluted EPS [+]	($0.95)	($0.04)	($0.82)
Growth	2396.6%	-95.4%

Shares outstanding (basic) [+]	219.2	170.5	86.3
Growth	28.5%	97.7%
Shares outstanding (diluted) [+]	219.2	475.7	86.3
Growth	-53.9%	451.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.